UNITED CAPITAL FINANCIAL ADVISORS, LLC
Position in COLL — Collegium Pharmaceutical, Inc
CIK 1463217
IRVING, TX
Position in COLL
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$464,880
+$131,601 QoQ
Shares Held
12,842
+27.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#148
of 277 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $5,747,253 across 11 Drug Manufacturers - Specialty & Generic names. COLL ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
19,404 | $1,394,371 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,054 | $1,085,989 | |
| 3 | VTRS |
Viatris Inc
|
44,259 | $702,832 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
This page
|
12,842 | $464,880 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
27,496 | $440,760 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
24,898 | $360,772 | |
| 7 | HLN |
Haleon plc
|
38,318 | $357,506 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
534 | $289,337 |
All Filings in COLL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $464,880 | 12,842 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $333,279 | 10,078 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||